Verhandeln, Drohen, Belohnen

{
  "authors": [
    "Joseph Cirincione"
  ],
  "type": "legacyinthemedia",
  "centerAffiliationAll": "dc",
  "centers": [
    "Carnegie Endowment for International Peace"
  ],
  "collections": [],
  "englishNewsletterAll": "ctw",
  "nonEnglishNewsletterAll": "",
  "primaryCenter": "Carnegie Endowment for International Peace",
  "programAffiliation": "NPP",
  "programs": [
    "Nuclear Policy"
  ],
  "projects": [],
  "regions": [
    "Iran"
  ],
  "topics": []
}

In The Media

Verhandeln, Drohen, Belohnen

By Joseph Cirincione

Published on Feb 23, 2005

This article appeared in the German online publication, Frankfurter Rundschau, on February 18, 2005. To view the full article, click here.

About the Author

Joseph Cirincione

Former Senior Associate, Director for NonProliferation

Recent Work

Report
Universal Compliance: A Strategy for Nuclear Security<br>With 2007 Report Card on Progress
- +2
  George Perkovich, Jessica Tuchman Mathews, Joseph Cirincione, …
Article
The End of Neoconservatism
- Joseph Cirincione

Iran

Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.

More Work from Carnegie India

Commentary
How WHO’s “One Health” Program Can Help India Tackle Monkeypox
With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.
Shruti Sharma
Paper
Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India
In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.
Shruti Sharma
Commentary
Combating Vaccine Hesitancy in India
Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.
Shruti Sharma
Commentary
How Should Countries Study Viruses Safely?
The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?
Shruti Sharma
Paper
Biological Risks in India: Perspectives and Analysis
India faces a host of biological risk factors. Drawing lessons from the coronavirus pandemic and prior biological disasters, India’s government should pursue new safety protocols and develop new institutions to manage future biological risk.
Shruti Sharma

More Work from Carnegie India

Commentary

How WHO’s “One Health” Program Can Help India Tackle Monkeypox

With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.

Shruti Sharma

Paper

Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India

In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.

Shruti Sharma

Commentary

Combating Vaccine Hesitancy in India

Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.

Shruti Sharma

Commentary

How Should Countries Study Viruses Safely?

The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?

Shruti Sharma

Paper

Biological Risks in India: Perspectives and Analysis

India faces a host of biological risk factors. Drawing lessons from the coronavirus pandemic and prior biological disasters, India’s government should pursue new safety protocols and develop new institutions to manage future biological risk.

Shruti Sharma